Td Waterhouse Canada Inc. Sorrento Therapeutics, Inc. Transaction History

Td Waterhouse Canada Inc.

  • $12.3 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 13, 2023
SELL
$0.17 - $1.19 $374 - $2,618
-2,200 Closed
0 $0
Q3 2022

Nov 13, 2023
SELL
$1.51 - $2.88 $604 - $1,152
-400 Reduced 15.38%
2,200 $3.37 Million
Q1 2022

Nov 13, 2023
BUY
$2.0 - $4.9 $3,400 - $8,330
1,700 Added 188.89%
2,600 $6.03 Million
Q4 2021

Nov 13, 2023
BUY
$4.65 - $7.23 $4,185 - $6,507
900 New
900 $4.26 Million

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.53M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email